Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor–2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study

Autor: Vaz-Luis, Ines, Seah, Davinia, Olson, Erin M., Wagle, Nikhil, Metzger-Filho, Otto, Sohl, Jessica, Litsas, Georgia, Burstein, Harold J., Krop, Ian E., Winer, Eric P., Lin, Nancy U.
Zdroj: In Clinical Breast Cancer August 2013 13(4):254-263
Databáze: ScienceDirect